Strategic Financial Services, Inc. - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 208 filers reported holding CONMED CORP in Q4 2018. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Strategic Financial Services, Inc. ownership history of CONMED CORP
ValueSharesWeighting
Q2 2024$694,864
-21.3%
10,024
-9.1%
0.04%
-22.8%
Q1 2024$882,802
-28.5%
11,024
-2.2%
0.06%
-34.5%
Q4 2023$1,233,849
-2.3%
11,267
-10.1%
0.09%
-11.2%
Q3 2023$1,263,348
-10.6%
12,5270.0%0.10%
-6.7%
Q2 2023$1,413,421
+4.2%
12,527
-4.1%
0.10%0.0%
Q1 2023$1,356,100
+17.2%
13,0570.0%0.10%
+12.9%
Q4 2022$1,157,372
+10.5%
13,0570.0%0.09%
+1.1%
Q3 2022$1,047,000
-16.2%
13,0570.0%0.09%
-13.2%
Q2 2022$1,250,000
-35.6%
13,0570.0%0.11%
-27.9%
Q1 2022$1,940,000
+3.1%
13,057
-1.7%
0.15%
+5.0%
Q4 2021$1,882,000
+8.3%
13,2770.0%0.14%
+2.2%
Q3 2021$1,737,000
-4.8%
13,2770.0%0.14%
-5.5%
Q2 2021$1,825,000
+5.2%
13,2770.0%0.14%
-0.7%
Q1 2021$1,734,000
+31.1%
13,277
+12.4%
0.15%
+22.7%
Q4 2020$1,323,000
+232.4%
11,815
+133.3%
0.12%
+190.2%
Q3 2020$398,000
+9.0%
5,0650.0%0.04%0.0%
Q2 2020$365,000
+25.9%
5,0650.0%0.04%
+5.1%
Q1 2020$290,000
-49.8%
5,065
-1.9%
0.04%
-40.9%
Q4 2019$578,000
+14.5%
5,165
-1.6%
0.07%
+1.5%
Q3 2019$505,000
+12.5%
5,2500.0%0.06%
+10.2%
Q2 2019$449,000
+2.7%
5,2500.0%0.06%
-1.7%
Q1 2019$437,000
+29.7%
5,2500.0%0.06%
+13.2%
Q4 2018$337,0005,2500.05%
Other shareholders
CONMED CORP shareholders Q4 2018
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 310,392$34,764,0004.40%
Iron Triangle Partners LP 148,317$16,612,0002.15%
Ranger Investment Management 294,664$33,002,0001.74%
Penn Capital Management Company, LLC 86,810$9,723,0001.23%
EARNEST PARTNERS LLC 1,575,336$176,438,0001.22%
Champlain Investment Partners, LLC 1,692,014$189,506,0001.09%
MOODY ALDRICH PARTNERS LLC 59,005$6,609,0001.07%
Hood River Capital Management LLC 232,412$26,030,0000.86%
OAK RIDGE INVESTMENTS LLC 80,775$9,047,0000.80%
Huber Capital Management LLC 18,620$2,085,0000.68%
View complete list of CONMED CORP shareholders